利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

59 条记录 (耗时 0.046 秒)

    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
    2.
    发明授权
    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof 有权
    哌嗪酰基哌啶衍生物，其制备和治疗用途

    公开(公告)号：US07468368B2

    公开(公告)日：2008-12-23

    申请号：US10516704

    申请日：2003-06-05

    申请人： Françoise Bono ,  Michaël Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    发明人： Françoise Bono ,  Michaël Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    IPC分类号： A61K31/50 ,  A61K31/501 ,  C07D241/04 ,  C07D401/00 ,  C07D403/00

    CPC分类号： C07D417/14 ,  C07D401/14

    摘要： The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; p is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents an aromatic group selected from: the said aromatic groups being unsubstituted or being mono- or disubstituted by a substituent selected independently from a halogen atom; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethyl radical; Preparation process and therapeutic application.

    摘要翻译： 本发明涉及通式（I）的取代的1-哌嗪基酰基哌啶衍生物，其中n为1或2; p为1或2; R1表示卤素原子; 三氟甲基; （C1-C4）烷基; （C 1 -C 4）烷氧基; 三氟甲氧基; R2表示氢原子或卤素原子; R3表示氢原子; 一组-OR5; 基团-CH 2 OR 5; 基团-NR 6 R 7; 一个-NR8COR9基团; 一组-NR8CONR10R11; 基团-CH 2 NR 12 R 13; 基团-CH2NR8CONR14R15; （C1-C4）烷氧基羰基; 一组-CONR16R17; 或者R 3构成与其连接的碳原子和哌啶环的相邻碳原子之间的双键; R 4表示选自以下的芳族基团：所述芳族基团是未取代的或被独立地选自卤素原子的取代基单取代或二取代; （C1-C4）烷基; （C 1 -C 4）烷氧基; 三氟甲基; 制备工艺及治疗应用。

    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
    4.
    发明授权
    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof 有权
    哌嗪酰基哌啶衍生物，其制备和治疗用途

    公开(公告)号：US07294628B2

    公开(公告)日：2007-11-13

    申请号：US10516808

    申请日：2003-06-05

    申请人： Françoise Bono ,  Michaël Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    发明人： Françoise Bono ,  Michaël Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    IPC分类号： A61K31/497 ,  A61K31/4965 ,  C07D241/04 ,  C07D295/00

    CPC分类号： C07D417/14 ,  C07D401/14

    摘要： The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4) alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents the aromatic group 1,3-thiazol-2-yl of formula: Preparation process and therapeutic application.

    摘要翻译： 本发明涉及通式（I）的取代的1-哌嗪基酰基哌啶衍生物，其中n为1或2; R 1表示卤素原子; 三氟甲基; （C 1 -C 4 -C 4）烷基; （C 1 -C 4 -C 4）烷氧基; 三氟甲氧基; R 2表示氢原子或卤素原子; R 3代表氢原子; 一个基团-OR 5; 基团-CH 2或OR 5; 基团-NR 6 R 7; 基团-NR 8 COR 9; 基团-NR 8 CONR 10 R 11; 基团-CH 2 NR 12 R 13; 基团-CH 2 NR 8 CONR 14 R 15 15; （C 1 -C 4 -C 4）烷氧基羰基; 基团-CONR 16 R 17 R 17; 或者R 3 3在其所连接的碳原子和哌啶环的相邻碳原子之间构成双键; R 4代表下式的芳族基团1,3-噻唑-2-基：制备方法和治疗应用。

    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof
    5.
    发明申请
    Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof 有权
    哌嗪酰基哌啶衍生物，其制备和治疗用途

    公开(公告)号：US20060167007A1

    公开(公告)日：2006-07-27

    申请号：US10516808

    申请日：2003-06-05

    申请人： Francoise Bono ,  Michael Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    发明人： Francoise Bono ,  Michael Bosch ,  Victor Dos Santos ,  Jean-Marc Herbert ,  Dino Nisato ,  Bernard Tonnerre ,  Jean Wagnon

    IPC分类号： A61K31/496 ,  C07D417/14 ,  C07D403/02

    CPC分类号： C07D417/14 ,  C07D401/14

    摘要： The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4) alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents the aromatic group 1,3-thiazol-2-yl of formula: Preparation process and therapeutic application.

    摘要翻译： 本发明涉及通式（I）的取代的1-哌嗪基酰基哌啶衍生物，其中n为1或2; R 1表示卤素原子; 三氟甲基; （C 1 -C 4 -C 4）烷基; （C 1 -C 4 -C 4）烷氧基; 三氟甲氧基; R 2表示氢原子或卤素原子; R 3表示氢原子; 一个基团-OR 5; 基团-CH 2或OR 5; 基团-NR 6 R 7; 基团-NR 8 COR 9; 基团-NR 8 CONR 10 R 11; 基团-CH 2 NR 12 R 13; 基团-CH 2 NR 8 CONR 14 R 15 15; （C 1 -C 4 -C 4）烷氧基羰基; 基团-CONR 16 R 17 R 17; 或者R 3 3在其所连接的碳原子和哌啶环的相邻碳原子之间构成双键; R 4代表下式的芳族基团1,3-噻唑-2-基：制备方法和治疗应用。

    Pyrozala-pyridyl aminoabkoxyphenol compounds
    8.
    发明授权
    Pyrozala-pyridyl aminoabkoxyphenol compounds 失效
    吡罗扎 - 吡啶基氨基氨基苯酚化合物

    公开(公告)号：US5182291A

    公开(公告)日：1993-01-26

    申请号：US716252

    申请日：1991-06-17

    申请人： Jean Gubin ,  Pierre Chatelain ,  Marcel Descamps ,  Dino Nisato ,  Henri Inion ,  Jean Lucchetti ,  Jean-Marie Mahaux ,  Jean-Noel Vallat

    发明人： Jean Gubin ,  Pierre Chatelain ,  Marcel Descamps ,  Dino Nisato ,  Henri Inion ,  Jean Lucchetti ,  Jean-Marie Mahaux ,  Jean-Noel Vallat

    IPC分类号： C07D209/30 ,  C07D213/70 ,  C07D213/71 ,  C07D215/36 ,  C07D235/22 ,  C07D261/10 ,  C07D277/36 ,  C07D307/64 ,  C07D471/04 ,  C07D495/04

    CPC分类号： C07D213/70 ,  C07C309/00 ,  C07C317/00 ,  C07D209/30 ,  C07D213/71 ,  C07D215/36 ,  C07D235/22 ,  C07D261/10 ,  C07D277/36 ,  C07D307/64 ,  C07D471/04 ,  C07D495/04

    摘要： Aminoalkoxyphenyl derivatives useful in the treatment of certain pathological syndromes of the cardiovascular system of formula: ##STR1## in which: B represents a --S--, --SO-- or --SO.sub.2 -- group,R.sub.1 and R.sub.2, which are identical or different, each denote hydrogen, a methyl or ethyl radical or a halogen,A denotes a straight- or branched-alkylene radical having from 2 to 5 carbon atoms or a 2-hydroxypropylene radical, in which the hydroxy is optionally substituted by a lower alkyl radical,R.sub.3 denotes an alkyl radical or a radical of formula:--Alk--R.sub.5in which Alk denotes a single bond or a linear- or branched-alkylene radical having from 1 to 5 carbon atoms and R.sub.5 denotes a pyridyl, phenyl, 2,3-methylenedioxyphenyl or 3,4-methylenedioxyphenyl radical or a phenyl group substituted with one or more substituents, which may be identical or different, selected from halogen atoms, lower alkyl groups or lower alkoxy groups,R.sub.4 denotes hydrogen or an alkyl radical orR.sub.3 and R.sub.4 when taken together, denote an alkylene or alkenylene radical having from 3 to 6 carbon atoms and optionally substituted with a phenyl radical or optionally interrupted by --O--, ##STR2## R.sub.6 denoting hydrogen or a lower alkyl or pheny radical, Cy represents a cyclic group with the proviso that when Cy represents a benzo[b]furyl or benzo[b]thienyl group and B represents a --SO.sub.2 -- group, R.sub.3 represents a radical --Alk--R.sub.5, as well as the N-oxide derivative thereof and a pharmaceutically acceptable salt thereof.

    摘要翻译： 用于治疗下列心血管系统的某些病理学综合征的氨基烷氧基苯基衍生物：其中：B表示-S-，-SO-或-SO 2 - 基团，R 1和R 2各自相同或不同， 表示氢，甲基或乙基或卤素，A表示具有2至5个碳原子的直链或支链亚烷基或2-羟基亚丙基，其中羟基任选被低级烷基取代，R 3 表示烷基或式Al-R 5的基团，其中Alk表示单键或具有1至5个碳原子的直链或支链亚烷基，R5表示吡啶基，苯基，2,3-亚甲二氧基苯基 或3,4-亚甲二氧基苯基或被一个或多个选自卤素原子，低级烷基或低级烷氧基的取代基取代的苯基，R4表示氢或烷基或R3和R4，当 一起表示 具有3至6个碳原子并且任选被苯基取代或任选地被-O - ， - 表示氢或低级烷基或苯基的-C 1-6的亚烷基或亚烯基，Cy表示环状基团，条件是 当Cy表示苯并[b]呋喃基或苯并[b]噻吩基，B表示-SO 2 - 基时，R 3表示基团-Alk-R 5，以及其N-氧化物衍生物及其药学上可接受的盐。